Journal
CLINICAL ENDOCRINOLOGY
Volume 95, Issue 2, Pages 295-302Publisher
WILEY
DOI: 10.1111/cen.14395
Keywords
c-ret proto-oncogene proteins; genetic testing; medullary carcinoma; multiple endocrine neoplasia type 2a; multiple endocrine neoplasia type 2b; phaeochromocytoma; primary hyperparathyroidism
Categories
Ask authors/readers for more resources
This study reported the experience of germline RET analysis for MTC patients and family members with MEN2-related conditions in the UK. While the detection rate was significant in patients with presumed sporadic MTC, the overall detection rate was lower than expected in this study.
Objective: Diagnostic germline RET analysis is offered to all patients with a diagnosis of medullary thyroid carcinoma (MTC), or other conditions associated with multiple endocrine neoplasia type 2 (MEN2) in the United Kingdom. Here, we report the experience of a single centre's germline RET analysis over a 21-year period. Design: Retrospective case-note review. Patients: All index patients referred to the Exeter Genomics Laboratory for diagnostic germline RET analysis between 1997 and 2018, and unaffected family members, undergoing predictive testing. Measurements: The rate and nature of pathogenic variant detection were recorded, as well as the indication for testing. Results: 1,058 index patients and 551 unaffected family members were tested. The overall rate of pathogenic variant detection was 10.2% amongst index patients and 29% amongst unaffected family members. The commonest indication was isolated MTC, and amongst the 690 patients with isolated MTC, 68 (9.9%) were found to harbour a RET pathogenic variant. Of those with presumed sporadic MTC, 8.5% were found to harbour germline RET pathogenic variants, compared with 36.4% of those with a family history of MEN2-associated conditions. Pathogenic variants were identified in 3.6% and 0% of patients with isolated phaeochromocytoma and primary hyperparathyroidism, respectively. Conclusions: Although the detection rate of RET germline pathogenic variants in patients with presumed sporadic MTC was significant, the overall detection rate in those with MTC was lower than expected in this series. Advances in RET analysis in response to reports of new variants over the last two decades are likely to have improved the pick-up rate in recent years.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available